Bone Grafts Engineered from Human Adipose-Derived Stem Cells in Perfusion Bioreactor Culture

• Published in: Tissue engineering. Part A 2010-01, Vol.16 (1), p.179-189
• Main Authors: Fröhlich, Mirjam, Grayson, Warren L., Marolt, Darja, Gimble, Jeffrey M., Kregar-Velikonja, Nevenka, Vunjak-Novakovic, Gordana
• Format: Article
• Language: English
• Subjects: Artificial bones; Bioreactors; Bone Substitutes; Cell culture; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Design and construction; Fat cells; Humans; Male; Materials; Original; Original Articles; Osteogenesis; Perfusion; Physiological aspects; Stem cells; Subcutaneous Fat - cytology; Subcutaneous Fat - metabolism; Tissue engineering; Tissue Engineering - methods
• ISSN: 1937-3341; 1937-335X
• DOI: 10.1089/ten.tea.2009.0164

We report engineering of half-centimeter–sized bone constructs created in vitro using human adipose-derived stem cells (hASCs), decellularized bone scaffolds, and perfusion bioreactors. The hASCs are easily accessible, can be used in an autologous fashion, are rapidly expanded in culture, and are capable of osteogenic differentiation. hASCs from four donors were characterized for their osteogenic capacity, and one representative cell population was used for tissue engineering experiments. Culture-expanded hASCs were seeded on fully decellularized native bone scaffolds (4 mm diameter × 4 mm thick), providing the necessary structural and mechanical environment for osteogenic differentiation, and cultured in bioreactors with medium perfusion. The interstitial flow velocity was set to a level necessary to maintain cell viability and function throughout the construct volume (400 μm/s), via enhanced mass transport. After 5 weeks of cultivation, the addition of osteogenic supplements (dexamethasone, sodium-β-glycerophosphate, and ascorbic acid-2-phosphate) to culture medium significantly increased the construct cellularity and the amounts of bone matrix components (collagen, bone sialoprotein, and bone osteopontin). Medium perfusion markedly improved the distribution of cells and bone matrix in engineered constructs. In summary, a combination of hASCs, decellularized bone scaffold, perfusion culture, and osteogenic supplements resulted in the formation of compact and viable bone tissue constructs.